PBS Biotech Revenue and Competitors

Location

#3326

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • PBS Biotech's estimated annual revenue is currently $14.7M per year.(i)
  • PBS Biotech's estimated revenue per employee is $155,000
  • PBS Biotech's total funding is $45M.

Employee Data

  • PBS Biotech has 95 Employees.(i)
  • PBS Biotech grew their employee count by 25% last year.

PBS Biotech's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
SVP Sales and MarketingReveal Email/Phone
3
VP Finance & Corporate ControllerReveal Email/Phone
4
Head EngineeringReveal Email/Phone
5
Sr. Director Quality Engineering and RegulatoryReveal Email/Phone
6
Executive Director, Bioprocess Research & DevelopmentReveal Email/Phone
7
Chief Operating Officer, EVPReveal Email/Phone
8
Executive Director, QualityReveal Email/Phone
9
Senior Director, Applications EngineeringReveal Email/Phone
10
Director Information TechnologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.5M27-7%N/AN/A
#2
$4096.4M108372%N/AN/A
Add Company

What Is PBS Biotech?

PBS Biotech, Inc. in Camarillo, CA designs & manufactures the industry's most advanced single-use bioreactors and disposable vessels and bags. Offering low shear, fast cell culture mixing and ease of scale the PBS product family allows biotech firms worldwide to gain operational efficiencies, cost savings, process flexibility and accelerate time to market in developing monoclonal antibodies (mAbs), proteins (non-mAbs), viruses & vaccines, stem cells, personalized medicine and more including the fast growing biosimilar market. The PBS team of scientists and engineers partners with our customers to provide an optimum and innovative bioprocess solution to their lab through production needs. Employing an easy to use and plug and play configuration, PBS bioreactors are fully scalable from 3 liter to 2500 liter. A patented low-shear Air Wheel(tm) mixing mechanism and intuitive touch screen operation provide maximum efficiency with minimum space requirements for a wide range of biotech processes from lab to cGMP production. Applications & processes with plant, animal and insect cell cultures include viral production, monoclonal antibodies (mAbs), perfusion, transient transfection, stem cells and personalized medicine. The PBS family of single-use bioreactors are designed by scientists for scientists. www.pbsbiotech.com Contact us: info@pbsbiotech.com

keywords:N/A

$45M

Total Funding

95

Number of Employees

$14.7M

Revenue (est)

25%

Employee Growth %

N/A

Valuation

N/A

Accelerator

PBS Biotech News

2022-04-17 - Single-Use Bioreactors Market Size And Forecast | Sartorius ...

... Getinge AB, Merck KGaA, PALL CORPORATION (DANAHER CORPORATION), Eppendorf AG, Bioengineering, Cellexus, PBS Biotech Inc., Distek Inc.

2022-04-17 - Bioreactor Market Size And Forecast | Solaris Biotechnology ...

Solaris Biotechnology s.r.l, Danaher Corporation, Finesse Solutions Applikon Biotechnology B.V., PBS Biotech Sartorius AG, Eppendorf AG, ZETA Holding GmbH, GE...

2021-08-16 - PBS Biotech Raises $10M in Funding

source: PBS Biotech webiste PBS Biotech, a Camarillo, CA-based single-use bioreactor manufacturer, closed a $10M funding round. BroadOak Capital Partners made the investment. The company intends to use the funds to expand and industrialize its portfolio of single-use bioreactor systems and co ...

2021-08-16 - PBS Biotech : Raises $10M to Provide Scale-Up Manufacturing Solutions for Cell Therapies

Single-use bioreactor manufacturer, PBS Biotech, recently closed a private $10M funding round with BroadOak Capital Partners. The financing will enable the company to expand and industrialize its portfolio of single-use bioreactor systems and contract process development services. “Cell therapi ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$33.5M956%N/A
#2
$23.6M968%N/A
#3
$33.9M9625%N/A
#4
$14.4M99N/AN/A
#5
$25.5M1047%N/A